Neogenomics (NEO) traded up 1.22 % during a 24 hours period ending at 06:34 PM Central Europe on Monday 26th. One Neogenomics stock can currently be bought for about USD 16.8 on popular exchanges. Current supply of Neogenomics stocks is 130.2 mn. Neogenomics has a current market capitalization of USD 2.2 bn and approximately USD 23.7 mn worth of Neogenomics was traded on exchanges in the last 24 hours. Since last month end, Neogenomics has traded -15.18 % down. Simple moving average of last 200 days is at USD 12.67. The highest price of past 52 weeks was recorded at USD 20.15 on 10/06/2026. 52 weeks low was at USD 7.07 on 03/30/2026.

Here is how related stocks have performed in the past 24 hours:

  • Hci (HCI) traded down -1.27 % and now trades at USD 202.41. Current market capitalisation for Hci is USD 2.5 bn. Current price/earnings ratio for Hci is 8.76.

  • Liberty Energy (LBRT) traded up 1.37 % and now trades at USD 15.93. Liberty Energy has a market capitalisation of USD 2.5 bn. Current price/earnings ratio for Liberty Energy is 63.98.

  • Banner (BANR) traded up 0.26 % and now trades at USD 70.89. Banner has a market capitalisation of USD 2.6 bn. Banner has a current price to earnings ratio of 11.91.

  • Dxc (DXC) traded up 0.06 % and now trades at USD 16.16. Current market capitalisation for Dxc is USD 2.6 bn. Dxc has a current price to earnings ratio of 22.9.

  • Viridian Therapeutics (VRDN) traded down -1.97 % and now trades at USD 22.92. Viridian Therapeutics has a market capitalisation of USD 2.5 bn.

About Neogenomics

NeoGenomics, Inc. is a health care company operating a network of clinical laboratories specializing in cancer genetics diagnostic testing services. The company’s offerings include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. These services are directed towards pathologists, oncologists, urologists, and hospitals. You can find more information about the company and its offerings on their website www.neogenomics.com . The company’s stock is traded on the Nasdaq. The Initial Public Offering (IPO) of NeoGenomics Inc. took place on November 2nd, 1999.